Question 1

What is Santhera Pharmaceuticals?

Accepted Answer

Santhera Pharmaceuticals is a Company.

Question 2

How often does Santhera Pharmaceuticals appear in global news?

Accepted Answer

Tracked across 3 news events drawn from 18 articles.

Question 3

When was Santhera Pharmaceuticals first tracked by Ergen?

Accepted Answer

First tracked on Apr 23, 2026.

Question 4

When was Santhera Pharmaceuticals last mentioned in news?

Accepted Answer

Last active on Jul 01, 2026.

Question 5

What is Santhera Pharmaceuticals's current news sentiment?

Accepted Answer

Aggregate sentiment score: 23 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Santhera Pharmaceuticals in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 3 events.

Question 7

What is the most recent event involving Santhera Pharmaceuticals?

Accepted Answer

AGAMREE Phase 1 Study Results (Jul 01, 2026, 6 articles).

Question 8

Who is Santhera Pharmaceuticals most connected to?

Accepted Answer

Top relationships: Nxera Pharma, Nxera Pharma.

Question 9

How did the "AGAMREE Phase 1 Study Results" event impact Santhera Pharmaceuticals?

Accepted Answer

Santhera Pharmaceuticals is the developer of AGAMREE and benefits from positive clinical trial results, which could lead to expanded indications and increased sales-based milestone payments and royalties from its licensing partners.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.